Press Room

This Thursday, the American Cancer Society will host the 49^th annual Great American Smokeout.

Today, ACS CAN released its first "Eye on Cancer Care" piece, which focuses on the dangers of the availability of “junk plans” that fail to provide the protections and health insurance coverage that cancer patients, survivors and those at risk of the disease need.

Lawmakers must turn their focus to long-term solutions. It is imperative that Congress moves swiftly to address two critical issues: ensuring health insurance costs do not spiral out of control for Marketplace plan coverage and passing a full-year budget that provides stability for American families. 

Open Enrollment for most of the Health Insurance Marketplaces begins tomorrow, Saturday, November 1, and because Congress still has not extended the enhanced premium tax credits, tens of millions of people, including cancer patients and survivors, are facing significant premium increases. 

A new paper in the Journal of Clinical and Translational Science finds that travel distance to National Cancer Institute (NCI)-funded sites remains a key barrier for patients wanting to participate in clinical trials or research at these locations.

Today, the U.S. House Committee on Ways and Means is expected to mark up the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act (H.R. 842).

As the September 30th government funding deadline nears, more than 700 cancer patients, survivors and advocates from every corner of the United States, including Washington, D.C., Guam, and Puerto Rico, are heading to Capitol Hill to make their voices heard. They will ask lawmakers to prioritize cancer research and prevention programs, along with other proven cancer-fighting policies, highlighting the real-life impact these investments have on patients, families and communities nationwide. 

Tomorrow, the House Appropriations Committee is scheduled to consider the draft FY26 appropriations bill approved on September 2^nd by the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies.  The bill includes an increase in funding for cancer research and cancer prevention and control programs.

More than 100 organizations representing millions of patients with serious health conditions and health care professionals sent a letter to Congress expressing their strong support for the Clinical Trial Modernization Act. Introduced in the House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-FL), the bipartisan legislation would help remove cost and geographic barriers to patient participation in clinical trials.

 A new ACS CAN study released in the Journal of the American Medical Association (JAMA) finds many patients aren’t made aware of the importance of pharmacogenomic (PGx) testing. A form of biomarker testing, PGx testing examines how variations in a patient’s inherited genes may impact how they respond to different drugs and can improve the effectiveness of treatment and reduce the risk of adverse drug reactions.